FDA Inspection 1103404 — Department of Defense - Air Force

Department of Defense - Air Force — FEI 1577551

The FDA completed an inspection of Department of Defense - Air Force on September 26, 2019 in Dayton, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 26, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dayton, OH (United States)

Citations

IDCFRDescription
1503821 CFR 610.47(a)(3)Notify Consignees [Collecting Establishment]
16121 CFR 606.160(a)(2)Determination of lot numbers and supplies